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Bacterial pneumonia is a leading cause of illness and death worldwide, but quantifying its
burden is difficult due to insensitive diagnostics. AlthoughWorld Health Organization
(WHO) protocol standardizes pediatric chest radiograph (CXR) interpretation for epidemio-
logic studies of bacterial pneumonia, its validity in adults is unknown.
Methods
Patients (age15 years) admitted with respiratory infections to two Guatemalan hospitals
between November 2007 and March 2012 had urine and nasopharyngeal/oropharyngeal
(NP/OP) swabs collected; blood cultures and CXR were also performed at physician clinical
discretion. ‘Any bacterial infection’ was defined as a positive urine pneumococcal antigen
test, isolation of a bacterial pneumonia pathogen from blood culture, or detection of an atypi-
cal bacterial pathogen by polymerase chain reaction (PCR) of nasopharyngeal/oropharyn-
geal (NP/OP) specimens. ‘Viral infection’ was defined as detection of viral pathogens by
PCR of NP/OP specimens. CXRs were interpreted according to the WHO protocol as hav-
ing ‘endpoint consolidation’, ‘other infiltrate’, or ‘normal’ findings. We examined associations
between bacterial and viral infections and endpoint consolidation.
Findings
Urine antigen and/or blood culture results were available for 721 patients with CXR interpre-
tations; of these, 385 (53%) had endpoint consolidation and 253 (35%) had other infiltrate.
Any bacterial infection was detected in 119 (17%) patients, including 106 (89%) pneumo-
coccal infections. Any bacterial infection (Diagnostic Odds Ratio [DOR] = 2.9; 95% confi-
dence Interval (CI): 1.3–7.9) and pneumococcal infection (DOR = 3.4; 95% CI: 1.5–10.0)
were associated with ‘endpoint consolidation’, but not ‘other infiltrate’ (DOR = 1.7; 95%
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CI: 0.7–4.9, and 1.7; 95% CI: 0.7–4.9 respectively). Viral infection was not significantly
associated with ‘endpoint consolidation’, ‘other infiltrate,’ or ‘normal’ findings.
Interpretation
‘Endpoint consolidation’ was associated with ‘any bacterial infection,’ specifically pneumo-
coccal infection. Therefore, endpoint consolidation may be a useful surrogate for studies
measuring the impact of interventions, such as conjugate vaccines, against bacterial
pneumonia.
Introduction
Bacterial pneumonia is an important cause of morbidity and mortality worldwide and Strepto-
coccus pneumoniae is the most common etiology, accounting for more than 30% of cases
where an etiology was determined [1, 2]. The use of the pneumococcal conjugate vaccine in
routine infant immunization programs has led to a decrease in invasive pneumococcal disease
among unvaccinated adults in developed countries [3–6]. It is not known whether similar indi-
rect (or herd) protection will be observed in low- and middle-income countries where the vac-
cine has been introduced [7], and where the burden of pneumococcal disease is much higher
[8]. The magnitude of indirect effects from pneumococcal conjugate vaccine may greatly
impact its cost-effectiveness and decisions about vaccine policy.
Accurately measuring the burden of bacterial, and specifically pneumococcal, pneumonia is
challenging [9, 10]. While definitions based on isolation of bacterial pathogens from blood cul-
ture are very specific, they are insensitive because only a small fraction of patients with bacterial
pneumonia have concurrent bacteremia [11–15]. Prior antimicrobial use, suboptimal sample
collection, improper specimen handling, and inadequate laboratory conditions for isolation of
fastidious organisms further limit the sensitivity of blood culture for detecting bacterial pneu-
monia, particularly in resource-limited settings. Definitions based on clinical signs and symp-
toms are sensitive for bacterial pneumonia, but they lack specificity, as viral pneumonia and
other clinical syndromes cannot be distinguished from bacterial pneumonia [10, 16]. Sputum
culture offers another option for the diagnosis of bacterial pneumonia, but adequate specimens
are only obtained in a small proportion of cases, limiting its use as a tool to measure pneumo-
nia burden [17]. While chest radiographs (CXR) are widely used for diagnosis of pneumonia,
variability in interpretation limits the validity of radiologic findings as epidemiologic endpoints
in studies of bacterial pneumonia [18].
The World Health Organization Department of Immunization, Vaccines, and Biologicals
developed a standardized approach for interpretation of CXRs for epidemiologic studies of
pneumonia in children and evaluations of vaccines against pneumonia [19–20]. The protocol
describes specific radiographic findings considered to be indicative of bacterial pneumonia
in children based on studies correlating these findings with bacterial infection [21–23]. Stan-
dardized interpretation is performed by a panel of CXR readers trained in the standardized
approach; each reader independently reviews the CXR without taking into consideration clini-
cal information about patients. CXRs are classified into three diagnostic categories: ‘endpoint
consolidation’, meaning that the CXR has findings consistent with a bacterial etiology; ‘other
infiltrate’, meaning that the CXR has abnormalities, but does not meet the criteria for endpoint
consolidation; and ‘no consolidation/infiltrate/effusion’, indicating the absence of these radio-
logic findings. Standardized interpretation has been used as an epidemiologic tool to measure
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the efficacy of pneumococcal conjugate vaccines as well as impact and effectiveness ofHaemo-
philus influenzae type B conjugate vaccines in clinical trials in young children [24–25]. This
approach could also be helpful in the assessment of non-vaccine interventions for bacterial
pneumonia.
There is limited experience with standardized interpretation of adult CXRs [26]. Adults
have a higher prevalence of chronic medical conditions, such as congestive heart failure, that
can cause radiographic findings similar to those found with bacterial pneumonia. The patho-
gens causing pneumonia in adults also more commonly include “atypical” bacteria such as
Mycoplasma pneumoniae that may cause lobar consolidation, more classically associated with
bacterial pneumonia, or an interstitial infiltrate, more classically associated with viral pneumo-
nia [2, 27]. An evaluation of the WHO standardized interpretation is needed to determine
whether this approach provides a useful tool for detection of bacterial pneumonia in adults.
We sought to characterize the performance of standardized interpretation for an epidemiologic
endpoint for bacterial pneumonia.
Methods
We used data from a hospital-based respiratory disease surveillance system in Guatemala
to examine associations between WHO CXR classifications and etiologies of respiratory infec-
tion among patients aged15 years. The surveillance system, which has been described in pre-
vious work documenting etiologies of respiratory illnesses, [28] has two sites: Santa Rosa,
which is located in the south of the country, and Quetzaltenango, in the western highlands.
Surveillance is conducted at the primary public hospital in each of the departments and both
facilities serve as regional reference hospitals. At the hospitals, study nurses reviewed ward reg-
isters for patients admitted for respiratory-related diagnoses as well as emergency department
logs for patients presenting with respiratory complaints. After study nurses obtain verbal con-
sent, they screen patients admitted with a respiratory-related admission diagnosis or chief
complaint for inclusion as acute respiratory infection cases. Cases of hospitalized acute respira-
tory infections are defined as evidence of acute infection and signs or symptoms of respiratory
disease (Table 1) occurring among patients of all ages admitted to one of the surveillance hospi-
tals. After enrollment, demographic and clinical information are obtained from chart review
and through patient interviews. During 2007–February 2012, study physicians performed a
respiratory physical examination on all patients who met the case definition and documented
pertinent respiratory system findings, such as rales and wheezes, using a standardized data
Table 1. Acute Respiratory Infection Case Definition*.
Evidence of acute infection Signs or symptoms of respiratory disease
Fever (38°C) Tachypnea
White blood cell (WBC) count < 3000 or >11000 Cough






* Hospitalized patients were considered to have acute respiratory disease if they met one or more of the
criteria for “evidence of acute infection” AND one or more of the criteria for “signs or symptoms of
respiratory disease.”
doi:10.1371/journal.pone.0133257.t001
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collection form. Starting in March 2012, physical examinations are no longer performed by
study physicians, but trained study nurses abstract pertinent respiratory findings on physical
examination from the patient medical record and document whether or not patients died dur-
ing their hospitalization. Nasopharyngeal and oropharyngeal (NP/OP) swabs are collected by
trained study nurses according to CDC protocols from patients of all ages [27]; these swabs are
tested for adenovirus, parainfluenza virus 1/2/3, respiratory syncytial virus, influenza A/B,
human metapnuemovirus, Chlamydophila pneumoniae, andMycoplasma pneumoniae by poly-
merase chain reaction (PCR). Urine specimens are collected only from patients15 years old
and are tested for S. pneumoniae using the Binax NOW (Alere, Traverse City, Michigan) urine
antigen assay [28].
Blood cultures and CXRs are ordered at the discretion of the treating physician; CXR images
are captured using a digital camera and are sent to [29] two radiologists who independently
conduct a standardized interpretation of each image. CXRs with dense, lobar consolidation
and/or a pleural effusion either on the same side as a pulmonary infiltrate or large enough to
obscure opacity, if one were present, are categorized as ‘endpoint consolidation’. Those with a
pulmonary infiltrate or effusion that did not meet the criteria for endpoint consolidation are
categorized as ‘other infiltrate’. CXRs without findings consistent with ‘endpoint consolidation’
or ‘other infiltrate’ are categorized as ‘no consolidation/infiltrate/effusion’, or ‘normal’. CXRs
whose features do not allow the interpretation of the endpoint consolidation characteristics are
considered uninterpretable, according to the WHO protocol [20]. A third radiologist interprets
CXRs for which the results of the first two interpretations are discordant, as well as 10% of
images with concordant interpretations for quality control. All three radiologists were trained
in the WHO standardized interpretation methodology. For this analysis, a final conclusion was
derived for each CXR based on radiologists’ individual interpretations. A conclusion of ‘end-
point consolidation’ required the agreement of at least two radiologists; a conclusion of end-
point consolidation from only one of the three radiologists was classified as ‘other infiltrate’.
CXRs were interpreted as ‘normal’ if all radiologists agreed that there were no findings consis-
tent with ‘endpoint consolidation’ or ‘other infiltrate’.
Hospitalized patients with acute respiratory infections were considered to have ‘pneumo-
coccal infection’ if their urine antigen test was positive or if S. pneumoniae was isolated from
blood culture. Patients were considered to have a ‘typical bacterial infection’ if they had either
evidence of a pneumococcal infection or if their blood culture grew any of the following patho-
gens: Haemophilus influenzae,Moraxella cattharalis, Staphylococcus aureus, Pseudomonas aer-
uginosa, and Klebsiella pneumoniae. Patients with a ‘typical bacterial infection’ or detection of
M. pneumoniae or C. pneumoniae on NP/OP swabs were classified as having ‘any bacterial
infection.’ Patients who did not meet definitions for ‘pneumococcal infection’, ‘typical bacterial
infection’, or ‘any bacterial infection’, but who had a positive PCR for a viral pathogen were
considered to have ‘viral infection.’
The surveillance protocol received approval from the institutional review boards of Univer-
sidad del Valle de Guatemala (Guatemala City, Guatemala), Centers for Disease Control and
Prevention (CDC) (Atlanta, GA, USA), and the Guatemala Ministry of Public Health andWel-
fare. Verbal consent was requested from patients when screening them for eligibility. Written,
informed consent was obtained from eligible patients willing to participate. For patients<18
years of age, parents or guardians were asked to provide written, informed consent for the par-
ticipation of the patient, and children aged seven through 17 years were asked for written,
informed assent.
In our analysis, we included only cases of hospitalized acute respiratory infection among
adult patients aged15 years with a standardized CXR interpretation and blood culture and/
or S. pneumoniae urine antigen results available. We described demographic and clinical
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characteristics of patients, stratified by whether they had CXR with endpoint consolidation,
other infiltrate, or normal patterns. We examined associations between the radiographic classi-
fications (‘endpoint consolidation’, ‘other infiltrate’, or ‘normal’) and etiologies (‘pneumococcal
infection’, ‘typical bacterial infection’, ‘any bacterial infection‘, and ‘viral infection’) using mul-
tivariable logistic regression with etiology as the dependent variable to calculate a diagnostic
odds ratio [30]. To adjust for potential confounders of associations between radiographic pat-
tern and etiology, we developed multivariable models, assessing patient characteristic variables
associated with endpoint consolidation with p<0.10 in unadjusted models for possible inclu-
sion in the adjusted models. We also quantified the sensitivity and specificity of endpoint
consolidation for detecting ‘pneumococcal infection’, ‘typical bacterial infection’, and ‘any bac-
terial infection’. We excluded patients with uninterpretable chest radiographs from the analysis
of sensitivity and specificity. All analyses were performed in SAS 9.3 (SAS Institute, Cary, NC).
Results
Between November 2007 and March 2012, 1,589 consenting patients aged15 years hospital-
ized with acute respiratory infection were enrolled in the surveillance system. CXRs were avail-
able for 796 (50%) patients. While a higher proportion of those who had a chest radiograph
had rales (p<0.01), there were no significant differences between patients who had CXR and
those who did not with respect to age (p = 0.75), sex (p = 0.43), ethnicity (p = 0.53), smoking
status (p = 0.29), chronic conditions (p = 0.56), fever (p = 0.10), proportion that needed ICU
admission (p = 0.09), or proportion that died (p = 0.68). Of the 796 patients with CXR, 721
(91%) had either blood culture or urine antigen testing and were included in the analysis
(Fig 1). Among 721 patients included in the analysis, 345 (48%) were male, the median age was
54 years (range: 15–96 years), and 713 (99%) had testing of NP/OP specimens for viral and
atypical bacterial pathogens performed.
Overall, 385 (53%) patients had endpoint consolidation on standardized interpretation, 253
(35%) had other infiltrate, and 79 (11%) were normal. Four CXRs (<1%) were uninterpretable.
Fig 1. Patients included in the Analysis of Performance Characteristics of Standardized
Interpretation.Of 1589 patients aged15 years who were hospitalized with acute respiratory infection, 793
(50%) were excluded because no chest radiograph with which to perform standardized interpretation was
performed. Of the remaining 796, 75 (10%) were excluded because no blood culture or urine antigen results
were available. This left 721 patients who were included in the analysis; of these 469 (65%) had urine antigen
results but no blood culture results, 208 (29%) had urine antigen and blood culture results, and 44 (6%) had
blood culture results without urine antigen results.
doi:10.1371/journal.pone.0133257.g001
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Demographic and clinical variables are presented in Table 2. Compared with having a normal
CXR, having endpoint consolidation was associated with a higher median age (p<0.01), male
sex (p<0.01), and history of smoking (p<0.04). There was no statistically significant difference
between the proportion of patients with endpoint consolidation and those with normal CXR
who had the chronic conditions: asthma, diabetes, cancer, heart disease, chronic lung disease,
chronic liver disease, or HIV/AIDS (p = 0.62). Rales on clinical examination (p<0.01) and
death (p = 0.05) were more common among patients with end point consolidation compared
to those with normal CXRs.




Other infiltrate n = 253
n(%)







Median age, years (range) 55 (15–95) 56 (15–96) 45 (15–84) <0.01
Age category <0.01
15–39 years 98 (25) 78 (30) 31 (39)
40–64 years 149 (39) 77 (30) 35 (44)
65 years 138 (36) 98 (39) 13 (16)
Male Sex 209 (54) 107 (42) 28 (35) <0.01
“Indigenous ethnicity” 177 (46) 92 (36) 26 (33) 0.06
Ladino ethnicity 193 (50) 153 (60) 51 (65) 0.06
Smoker 51 (14) 24 (10) 4 (5) 0.04
History of Chronic
Conditions**
174 (47) 130 (53) 40 (50) 0.62
Asthma / chronic lung disease 60 (16) 55 (22) 20 (25) 0.05
Diabetes 53 (14) 28 (11) 5 (6) 0.06
Heart disease 29 (8) 24 (10) 4 (5) 0.63
Chronic liver disease 11 (3) 6 (2) 1 (1) 0.70
HIV/AIDS 7 (2) 2 (1) 3 (4) 0.39
Income <Q 1,000 246 (84) 170 (85) 51 (86) 0.84
Electricity in the home 348 (94) 227 (91) 72 (92) 0.61
Clinical Findings
Fever (Temperature 38°C) 126 (33) 81 (32) 29 (37) 0.49
Fever (by history) 257 (67) 156 (62) 53 (68) 0.88
Hypoxemia *** 130 (40) 85 (40) 23 (34) 0.33
Chills 146 (50) 86 (46) 37 (59) 0.19
Runny nose 183 (49) 140 (57) 42 (53) 0.47
Sneezing 190 (51) 153 (62) 49 (63) 0.06
Physical Exam Findings
Wheezing 90 (25) 78 (32) 28 (36) 0.05
Rales 323 (89) 203 (84) 51 (65) <0.01
Outcome
Death 47 (13) 17 (7) 4 (5) 0.05
* Fisher’s exact test, except for median age which was performed using Mann-Whitney U test.
** Chronic conditions include asthma, diabetes, cancer, heart disease, chronic lung disease, chronic liver disease, and HIV/AIDS.
*** Oxygen saturation <90% or <88% in Quezaltenango.
doi:10.1371/journal.pone.0133257.t002
Standardized Interpretation for Pneumonia Studies in Adults
PLOS ONE | DOI:10.1371/journal.pone.0133257 July 24, 2015 6 / 12
Of the 677 patients tested by urine antigen assay, 102 (15%) were positive. Among 252
patients who underwent blood culture, 6 (2%) had S. pneumoniae isolated (including 2 that
also had positive urine antigen testing). Thus, a total of 106 (15%) had ‘pneumococcal infec-
tion’. Blood cultures also detected 6 (2%) patients with S. aureus, 1 with P. aeruginosa, and 1
with K. pneumoniae, yielding a total of 114 (16%) with ‘typical bacterial infection’.M. pneumo-
niae and/or C. pneumoniae infections were detected by PCR in 7 patients overall, including 2
patients that also had ‘typical bacterial infection’ (both with a positive S. pneumoniae urine
antigen test) as well as 5 others (3M. pneumoniae, 2 C. pneumoniae). Thus, 119 (17%) patients
met the criteria for ‘any bacterial infection.’
Of the 721 included patients, 214 (30%) tested positive for viral infection; 54 (25%) with
respiratory syncytial virus, 71 (33%) with influenza, 45 (21%) with parainfluenza, 44 (21%)
with adenovirus, and 24 (11%) with human metapneumovirus. Among the 214 patients with a
virus detected, multiple viruses were detected in 24 (11%), and ‘any bacterial infection’ was
detected in 36 (17%).
Endpoint consolidation was positively associated with ‘pneumococcal infection’, ‘typical
bacterial pneumonia’, and ‘any bacterial pneumonia’, compared with normal CXRs (Table 3).
All of these associations remained significant after adjusting for age, sex, ethnicity, smoking
status, presence of diabetes, and presence of asthma/chronic lung disease. Adjustment changed
the diagnostic odds ratio by less than 10% for each of the measured associations. There was no
significant association between ‘pneumococcal infection’, ‘typical bacterial infection’, or ‘any
bacterial infection’ and the other infiltrate category compared with normal CXRs (Table 4).
‘Viral infection’ was not significantly associated with endpoint consolidation or other infiltrate.
Among 106 patients with ‘pneumococcal infection’, endpoint consolidation was noted in 72,
yielding a sensitivity of 68% (95% CI: 59%–76%). Among 611 patients without ‘pneumococcal
Table 3. Association between endpoint consolidation and different types of infections.
Infection Type Endpoint consolidation
N = 385 n(%)
Normal N = 79
n(%)
Unadjusted diagnostic odds ratio
(95% CI)




72 (19) 6 (8) 3.4 (1.5–10.0) 3.3 (1.3–9.7)
Typical bacterial
infection
76 (20) 6 (8) 2.9 (1.4–7.9) 2.7 (1.2–7.4)
Any bacterial infection 81 (21) 5 (6) 3.2 (1.5–8.6) 2.9 (1.3–7.9)
Viral infection alone 106 (28) 23 (29) 0.9 (0.5–1.6) 0.9 (0.5–1.7)
* Adjusted for age, sex, ethnicity, smoking status, presence of diabetes, and presence of asthma/chronic lung disease.
doi:10.1371/journal.pone.0133257.t003
Table 4. Association between other infiltrate and different types of infections.
Infection Type Other Infiltrate N = 253
n(%)
Normal N = 79 n
(%)
Unadjusted diagnostic odds ratio
(95% CI)




32 (13) 6 (8) 1.9 (0.8–5.8) 2.0 (0.8–6.3)
Typical bacterial
infection
32 (13) 6 (8) 1.8 (0.8–4.8) 1.7 (0.7–4.9)
Any bacterial infection 29 (11) 5 (6) 1.7 (0.8–4.8) 1.7 (0.7–4.9)
Viral infection alone 84 (33) 23 (29) 1.2 (0.7–2.1) 1.4 (0.8–2.5)
* Adjusted for age, sex, ethnicity, smoking status, presence of diabetes, and presence of asthma/chronic lung disease.
doi:10.1371/journal.pone.0133257.t004
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infection’, the radiograph pattern was not endpoint consolidation (i.e. normal or other infiltrate)
for 298, resulting in a specificity of 49% (95% CI: 45%–53%).
Discussion
Standardized interpretation of adult CXRs identified persons with acute respiratory infection
that were more likely to have bacterial infection, independent of age, sex, ethnicity, smoking
status, and presence of chronic conditions. ‘Endpoint consolidation’ was associated with bacte-
rial infection, and this was driven by the association with pneumococcal infection, since rela-
tively few infections with other bacterial pathogens were found. Endpoint consolidation was
not associated with viral infection alone and other infiltrate was not associated with bacterial
or viral infection. Similar to published performance characteristics of pneumococcal urinary
antigen testing [31–34], standardized interpretation of adult CXR offers improved sensitivity
for pneumococcal infections compared with blood-culture-based definitions and improved
specificity compared with clinical definitions.
We also found that endpoint consolidation had moderate sensitivity and specificity for
detecting pneumococcal infection, the most common bacterial infection. Because a useful epi-
demiologic definition of bacterial infections will be both sensitive and specific, we measured
the diagnostic odds ratio, which combines measures of sensitivity and specificity into a single
indicator, in addition to calculating sensitivity and specificity directly [30]. While neither the
sensitivity nor specificity of ‘endpoint consolidation’ was optimal for detecting pneumococcal
infection, the balance between sensitivity and specificity for epidemiologic endpoints is a trade-
off. The most sensitive definitions, such as clinical case definitions, are useful for estimating the
maximum burden of disease; however, their lack of specificity limits their utility for estimating
the impact of specific public health interventions against pneumonia, such as pneumococcal
vaccines. Blood-culture-confirmed etiologies, on the other hand, provide a high specificity, but
may vastly underestimate the burden of pneumococcal disease and thus the population-level
impact of vaccines and other public health interventions against pneumococcal pneumonia
[15, 35]. Blood culture, which requires trained personnel, equipment, and specific transport
conditions, may not be feasible in many resource-limited settings. The pneumococcal urine
antigen test has a sensitivity of 77 to 92% for bacteremic pneumococcal pneumonia and 52
to 78% for non-bacteremic pneumococcal pneumonia; reported specificities have ranged from
67 to 90% [32–35]. This represents higher sensitivity compared with blood culture, and an
increased specificity compared with clinical case definitions. However, with a cost of approxi-
mately $40 per test, pneumococcal urine antigen is not widely available in resource-poor set-
tings [36]. Standardized interpretation may offer similar performance characteristics while
making use of CXRs, which are often obtained for clinical purposes even in resource-limited
settings.
Although the utility of standardized interpretation has been previously documented for
pediatric CXRs, there is only limited experience with this approach for adult CXRs. Although
one study has used standardized interpretation to describe the burden of community-acquired
pneumonia in adults, the process was not validated in this analysis [26]. Documentation of an
association between ‘endpoint consolidation’ and ‘pneumococcal infection’ in adults suggests
that standardized interpretation is useful for measuring pneumococcal infection among adults.
Notably, the association between ‘endpoint consolidation’ and ‘pneumococcal infection’ was
consistent even after adjusting for age, ethnicity, smoking status, presence of diabetes, and
presence of asthma/chronic lung disease. Thus, standardized interpretation is a tool that can
potentially be used to measure herd effects in adults resulting from use of pneumococcal conju-
gate vaccine in children [37, 38]. In recent years, the pneumococcal conjugate vaccine has been
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increasingly introduced in the routine immunization programs of low- and middle-income
countries. However, it is unknown whether the vaccine will result in herd protection in that
context. Documentation of herd effects will inform vaccine cost-benefit considerations by giv-
ing policy makers a more accurate assessment of the societal benefits of the vaccine program.
This analysis has limitations. CXRs and blood cultures were obtained at physician discretion
and were not performed for all patients. We are uncertain of the impact that exclusion of those
patients may have had on our results. Patients for whom CXRs were obtained were more likely
to have rales, a clinical finding associated with bacterial pneumonia, on physical exam; there-
fore, our hypothesis is that patients in the cohort without CXRs were less likely to have bacte-
rial pneumonia and more likely to have viral pneumonia compared with those patients for
whom CXR was obtained. Because CXR findings among patients with viral infections were
relatively equally distributed between the three CXR classifications, our hypothesis is that
addition of these patients would have little effect on the associations we observed. Secondly,
patients who did not have clinical pneumonia may have been included since the criteria for
acute respiratory infection were quite broad, likely including patients with upper respiratory
infections who did not require that the patient have suggestive clinical features for pneumonia.
The majority of these patients would likely have normal CXR findings and negative testing for
bacterial pathogens, resulting in a minimal impact on the observed association between bacte-
rial pneumonia and ‘endpoint consolidation.’ Thirdly, multiple study physicians examined
patients; therefore, there may have been some inter-observer variability in the physical exam
findings. However, since the radiologists did not have access to the results of the physical exam
findings when making interpretations, this variability did not affect the findings. Additionally,
since the diagnostic gold standards for bacterial pneumonia, urine antigen and blood culture,
have limited sensitivity, some patients may have been misclassified. Since we had no assay to
test for non-pneumococcal, non-bacteremic pneumonia, very few non-bacteremia pneumonia
cases with etiologies other than S. pneumoniae were found. Perhaps this is the reason that a
bacterial or viral etiology was identified for only 45% of patients with ‘endpoint consolidation’
and 48% of patients with ‘other infiltrate.’ If, as we suspect, more sensitive diagnostics would
identify more patients with bacterial infections among those with ‘endpoint consolidation’, the
strength of the observed association between ‘endpoint consolidation’ and ‘any bacterial infec-
tion’ would increase. Finally, our conclusions about associations between pneumococcal infec-
tions and standardized interpretation findings cannot be generalized to pneumonia caused by
other pathogens or to settings where the distribution of pathogens may be different from Gua-
temala. However, given that prospective surveillance identified S. pneumoniae as the most
commonly identified bacterial pathogen in Guatemala, consistent both with our findings and
data in other countries, our findings may be generalizable to a variety of settings [2, 28]. Finally,
PCR of NP/OP swabs may result in detection of infections in healthy persons; therefore there
may have been some misclassification among those considered to have viral infections and
may explain the relatively high proportion of persons with normal CXRs and ‘viral infection’
[39].
By identifying adults more likely to have pneumococcal infections, standardized interpreta-
tion of adult CXRs may be useful for measuring the indirect effects of vaccinating infants with
the pneumococcal conjugate vaccine. Although further work will be necessary to validate and
optimize the use of standardized interpretation in adults, this use of CXRs, which are widely
available, even in resource-poor settings, is a feasible way to estimate adult pneumonia disease
burden and the impact of public health interventions such as pneumococcal conjugate vaccine
on adult pneumonia. As Guatemala introduced the 13-valent pneumococcal conjugate vaccine
in November 2012, standardized interpretation of adult CXR may be useful for measuring indi-
rect effects in this setting.
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